Veterinary Medicines

COGLAVAX

Authorised
  • Clostridium perfringens, type A, alpha toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium novyi, type B, alpha toxoid
  • Clostridium septicum, toxoid
  • Clostridium tetani, toxoid
  • Clostridium chauvoei, Inactivated
Download as PDF

Product identification

Medicine name:
КОГЛАВАКС
COGLAVAX
Active substance:
  • Clostridium perfringens, type A, alpha toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium novyi, type B, alpha toxoid
  • Clostridium septicum, toxoid
  • Clostridium tetani, toxoid
  • Clostridium chauvoei, Inactivated
Target species:
  • Cattle
  • Sheep
  • Goat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium perfringens, type A, alpha toxoid
    2.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type C, beta toxoid
    10.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type D, epsilon toxoid
    5.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium novyi, type B, alpha toxoid
    3.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium septicum, toxoid
    2.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium tetani, toxoid
    2.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium chauvoei, Inactivated
    90.00
    80% Protective Dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
    • Sheep
    • Goat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI04AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Animal Health Bulgaria EOOD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-1505
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 2/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."